Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Cannabinoids for epilepsy.
David Gloss
,
Barbara Vickrey
Environmental Medicine
Friedman Brain Institute
Icahn School of Medicine at Mount Sinai
Institute for Exposomic Research
Neurology
Research output
:
Contribution to journal
›
Review article
›
peer-review
104
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cannabinoids for epilepsy.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Epilepsy
100%
Cannabinoids
100%
Marijuana
75%
Cannabidiol
75%
Adverse Effects
50%
Treatment Group
50%
Antiepileptic Drugs
50%
Adverse Events
25%
Randomized Controlled Trial
25%
Number of Patients
25%
Cochrane Library
25%
PubMed
25%
MEDLINE
25%
Cochrane Central Register of Controlled Trials
25%
Patients with Epilepsy
25%
Cochrane
25%
Extracted Data
25%
ISI Web of Knowledge
25%
Treatment Agent
25%
Life Data
25%
Seizure Freedom
25%
CINAHL
25%
United States of America
25%
Objective Quality of Life
25%
People with Epilepsy
25%
Letters to the Editor
25%
Responder Rate
25%
Issue 4
25%
Efficacy of Cannabinoids
25%
Interseizure Interval
25%
EBSCOhost
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabis
100%
Cannabidiol
100%
Cannabinoid
100%
Treatment Group
66%
Adverse Event
33%
Randomized Controlled Trial
33%
Anticonvulsive Agent
33%